GENVEYOR® — gene conveyor, the conveyor for next-generation medicine. Schematic of the AccuLNP™ delivery route across a cell membrane: 1, a nucleic acid–LNP; 2, uptake into the cell; 3, RNA or DNA released on pH change. Marked: advanced LNP technology, precision delivery, high efficiency and safety, enabling the future of gene therapy and beyond.

AccuLNP™ Transfection Kit Series

Delivering superior performance across mRNA · pDNA · siRNA · circular ssDNA

  • ~60 s encapsulation
  • >90% cell viability
  • mRNA · pDNA · siRNA · cssDNA
  • In vivo (preclinical)
Summary comparison of the AccuLNP kit against Lipofectamine and PEI across seven metrics: transfection efficiency, cell viability, payload versatility, primary immune cells, in vivo delivery, targeted delivery, and reproducibility and scalability. AccuLNP is rated highest on every row.

Our Service

Explore GENVEYOR® LNP services

About us

The platform

AccuLNP™ is a lipid mediated, multi-component system for the delivery of nucleic acids. We have a versatile and diverse library of over several hundred proprietary ionizable lipids with novel chemical structures which serves as the major component of the delivery vehicle.

Our studies have shown that the composition of our delivery vehicle can be tailored for the encapsulation of different types of nucleic acids (e.g., mRNA, siRNA, oligonucleotides and DNA) to achieve high payload encapsulation efficiency, superior transfection efficiency, and low toxicity.

AccuLNP-based transfection reagent can be applied for a variety type of applications in the field of biological research where delivery of nucleic acid is needed.

Where we work

Hillsborough, New Jersey, USA
LNP co-development (CRO)
Shenzhen, China
GMP manufacturing (CMO)

off

Get 20% off your first order

Tell us who you are and where you work. We send the first-order discount code and the protocol pack for your cargo — nothing else.

Prefer email? Write to contact@genveyor.com, or use the contact form.